Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

VEGF inhibitors discovered by Zeneca

Nov. 17, 1997

NIH seeks licensees for raf protein kinase therapeutics

Nov. 17, 1997

Ribozyme, Chiron initiate product development of RPI-4610

Nov. 14, 1997

ImClone receives SBIR grant for angiogenesis research

Nov. 14, 1997

Potent antineoplastic camptothecin derivative identified

Nov. 14, 1997

TK inhibitors under development at Dr. Karl Thomae

Nov. 13, 1997

Sankyo synthesizes azole aromatase inhibitors

Nov. 13, 1997

Mitsui Toatsu reveals novel antitumor agents

Nov. 12, 1997

Radicicol derivatives with antitumor activity from Sankyo

Nov. 12, 1997

MDR-reversing agents reported by Nikken Chemicals

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...